Home › Trial NCT01050985
A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer
- Trial IDNCT01050985
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorGeorgetown University
- Enrollment47
- Start date2010-07
- ConditionsAdvanced Solid Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.